Pollack, S., Heppner, G.H., Brawn, R.J., and Nelson, K.   "Specific killing of tumor cells in vitro in the presence of normal lymph node cells and sera from tumor-bearing mice.  Int. J. Cancer 9:316-323, 1972.

Pollack, S.B., and Nelson, K.  "Protection against challenge with MSV by immune spleen cells:  Effect of stage of donor response."  Transplantation 15:510-513, 1973.

Pollack, S.B., and Nelson, K.  "Effects of carrageenan and high serum dilution on synergistic cytotoxicity to tumor cells."   J. Immunol. 110:1440-1443, 1973.

Pollack, S., and Nelson K.   "Early appearance of a lymphoid arming factor and cytotoxic lymph node cells after tumor induction."  Int. J. Cancer 14:522-529, 1974.

Nelson, K., Pollack, S.B., and Hellstrom, K.E.  "Specific anti-tumor responses by cultured immune spleen cells.  I.  "In vitro culture method and initial characterization of factors which block immune cell-mediated cytotoxicity in vitro."  Int. J. Cancer 15:806-814, 1975.

Nelson, K., Pollack, S.B., and Hellstrom, K.E.  "Specific anti-tumor responses by cultured immune spleen cells.  II.  Culture supernatants induce specific anti-tumor cytotoxicity by non-immune lymphoid cells in vitro."  Int. J. Cancer 16:292-300, 1975.

Pollack, S., and Nelson, K.  "Evidence for two factors in sera of tumor-bearing mice which induce specific lymphoid cell-dependent cytotoxicity:  IgG2 and a rapid appearing factor not associated with IgG or IgM."  Int. J. Cancer 16:339-346, 1975.

Pollack, S., Nelson K., and Grausz, J.D.  "Killer cells from murine spleens: Effectors of antibody-dependent cellular cytotoxicity."  Transplant.  Proc. 7:477-482, 1975. 

Nelson, K., Pollack, S.B., and Hellstrom, K.E.  "Specific anti-tumor responses by cultured immune spleen cells:  III.  Further characterization of cells which synthesize factors with blocking and antiserum dependent cellular cytotoxic (ADC) activities."  Int. J. Cancer 16:539-549, 1975.

Nelson, K., Pollack, S.B., and Hellstrom, K.E.  "In vitro synthesis of tumor-specific factors with blocking and antibody-dependent cellular cytotoxicity (ADC) activities."  Int. J. Cancer 16:932-941, 1975.

Pollack, S., and Nelson, K.  "Production of tumor-specific inducer of cellular cytotoxicity by lethally irradiated mice."  Int. J. Cancer 18:250-254, 1976.

Pollack, S., Nelson, K., Grausz, J.D.  "Separation of murine effector cells which mediate antibody-dependent cytotoxicity (ADC) to erythrocyte and tumor targets."  J. Immunol. 116:944-946, 1976.

Hellstrom, I., Hellstrom, K.E., Kall, M.A., Nelson, K., and Pollack, S.B. "Suppression of cell-medicated cytotoxicity by lymphocytes from tumor-bearing animals."  Transpl. Proc. 8:225-264, 1976.

Nelson, K., Sjogren, H.O., and Rosengren, J.E. "Detection of antibodies to embryonic antigens in sera of multiparous or colon tumor-bearing rats by a new indirect immunofluorescence assay."  Int. J. Cancer 20:227-233, 1977.

Nelson, K., and Sjogren, H.O. "Effects of presensitization in vivo on cell-mediated responses to embryonic antigens in vitro."  Int. J. Cancer 10:108-114, 1978.

Malmstrom, P., Nelson, K., Jonsson, A., Sjogren, H.O., Walter, H. and Albertsson, P.A.  "Separation of rat leukocytes by countercurrent distribution in aqueous two-phase systems.  I. Characterization of subpopulations of cells."  Cell. Immunol. 37:409-421, 1978.

Nelson, K., Malmstrom, P., Jonsson, A., and Sjogren, H.O.  "Separation of rat leukocytes by countercurrent distribution in aqueous two-phase systems.  II. Subpopulations which mediated selective and non-selective lysis of normal and colon carcinoma cells in vitro."  Cell.  Immunol. 37:422-431, 1978.

Nelson, K., Cory, J., Hellstrom, I., and Hellstrom, K.E.  "T-T hybridoma product specifically suppresses tumor immunity."  Proc. Natl. Acad. Sci. 77:2866-2870, 1980.

Cory, J., Nelson, K., Forstrom, J.W., Hellstrom, I., and Hellstrom, K.E.  "A T cell hybridoma suppressor factor which binds tumor antigen."  In: Monoclonal Antibodies and T Cell Hybridomas. (G-J.  Hammerling, U. Hammerling, and J.F. Kearney, eds.)  Elsevier/North Holland Biomedical Press, Amsterdam, pp. 191-197, 1981.

Hellstrom, K.E., Nelson, K., Cory, J., Forstrom, J.W. and Hellstrom I.  "A tumor-specific suppressor factor produced by a murine T cell hybridoma."  In: Hybridomas in Cancer Diagnosis and Treatment,  M.M. Mitchell and H.F. Oettgen, eds., Raven Press, N.Y., pp. 197-198, 1982.

Hellstrom, I., Hellstrom, K.E., and Nelson, K. "Antigen specific suppression ('blocking') factors in tumor immunity."  In:  Pathological Membranes. A Nowotny, ed., Plenum Press, N.Y., pp. 365-388, 1983.

Forstrom, J.W., Nelson, KA., Nepom, G.T., Hellstrom I., and Hellstrom, K.E.  "Immunization to a syngeneic sarcoma by a monoclonal auto-anti-idiotypic antibody."  Nature 303:627-629, 1983.

Nelson, KA., Hellstrom, I., and Hellstrom, K.E.  "Tumor antigen-specific suppressor factors made by T cell hybridomas."  In:  T-Cell Hybridomas (J.J. Taussig, ed.) CRC Press, Inc., Boca Raton, Florida, pp. 129-138, 1985.

Hellstrom, K.E., Hellstrom, I., Nelson, K., and Nepom, G.T.  "Suppressor factors in tumor immunity".  Transplant. Proc.  First International Conference on Carcinogensis, Immunology and Transplantation:  Environmental Host Factors,"  April 25-27, 1983, Roswell Park Memorial Institute, Buffalo, N.Y.

Nepom, G.T., Nelson, KA., Holbeck, S.L., Hellstrom, I., and Hellstrom, K.E.  Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice.  Proc. Natl. Acad. Sci. 81:2864-2867, 1984.

Nelson, KA. and Nepom, G.T.  "Idiotypic Networks in Tumor Immunity."  In:  Paradoxes in Immunology (Hoffman, G.W., Levy, J.G., and Nepom, G.T., eds.)  CRC Press, Boca Raton, Florida, pp. 177-182, 1986.

Amar, A., Radka, S.F. Holbeck, S.L., Kim, S.J., Nepom, B.S. Nelson, KA. and Nepom, G.T. Characterization of specific HLA-DQ alpha allospecificities by genomic, biochemical and serologic analysis.  J. Immunol. 138:3986-3990, 1987.

Nelson, KA., George, E., Swenson, C., Forstrom, J.W. and Hellstrom, K.E. Immunotherapy of murine sarcomas with auto-antiidiotypic monoclonal antibodies which bind to tumor-specific  T cells.  J. Immunol. 139:2110-2118, 1987.

Hellstrom, K.E., Lee, V., Nelson, K., and Hellstrom, I. Induction and analysis of tumor immunity using anti-idiotypic monoclonal antibodies. Monographs in Allergy 22: 212-221, 1987.

Nelson, KA., Bodmer, J.G., Martin, A., Navarette, C., and Strong, D.M.  Micro EIA and monoclonal antibodies.  In "Immunobiology of HLA. vol.1."  B. Dupont ed., Springer-Verlag, New York, pp 292-300, 1989.

Radka, S.F., Nelson, KA. and Johnston, J.V. "HLA-DQw3-related determinants: analysis of subunit and spatial relationships." Human Immunol. 25:225-236, 1989.

Breysse, P., Couser, W.G., Alpers, C.E., Nelson, K., Gaur, L., Zawadski, I., and Johnson, R. Membranous nephropathy and formaldehyde exposure. Annals Int. Med. 120:396-397, 1994.

Reiner, A.P., Teramura, G., Nelson, K., and Slichter, S.J. A platelet monoclonal antibody-inhibition assay for detection of glycoprotein IIb/IIIa-related platelet alloantibodies. J Immunol. Meth.,184:153-162, 1995.

Nelson, K.  The human  leukocyte antigen system and the immune response to it. Clinical Orthopaedics,  326:35-42, 1996.

Weyrich, J., Andrews, R., Nelson, K.A., Thomas, R. and Andrews, R.  Intrathymic stem cell transplantation produces hematopoetic microchimerism in human-to-baboon xenografts. Transplantation Proceedings, 28(2):760, 1996.

Allen, M.D., Weyrich, J., Nelson, K.A., Akimoto, H., Gaur, L., Thomas, R., and Andrews, R. Prolonged allogeneic and xenogeneic microchimerism in unmatched primates without immunosuppression by intrathymic implantation of CD34+ donor marrow cells. Cellular Immunology, 181:127-138, 1997.

Aziz, A., Nelson K.A., Hassantash, S.A., Levy, W., Kruse, A., Reichenbach, D., Himes, V., Fishbein, D. and Allen, M.D.  The clinical significance of flow cytometry crossmatching in cardiac transplantation. International Society for Heart and Lung Transplantation, 17(7):686-92, 1998.

Cotler, S.J., Gaur, L.K., Gretch, D.R., Wile, M., Strong, D.M., Bronner, M.P., Carithers, R.L., Edmond, M.J., Perkins, J.D. and Nelson, K.A.  Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation. Tissue Antigens 52(5):435-43, 1998.

Price, T.H., Bowden, R.A., Boeckh, M., Bux, J., Nelson, K., Liles, C., and Dale, D.C.  Phase I/II trial of neutrophil transfusions from donor stimulated with G-CSF and dexamethasone for treatment of infections in hematopoeitic stem cell transplantation patients.  Blood, 95(11):3302-09, 2000.

Nelson, K.A. HLA Typing. In “Clinical Immunology 2e”  Rich R, Fleisher TA, Shearer WT, Schroeder Jr. HW,  Kotzin B, eds. Harcourt International, London, UK. 2001.

Nitta, Y., Gaur, L.K., Nelson, K., Andrews, R.G., deFries, R., Thomas, R., and Allen, M.D. Intrathymic donor stem cell fractions increase chimerism but don’t check alloantibody or alloreactivity responses in non-human primates.  Transplantation Proceedings, 33:110-1, 2001.

Nitta, Y., Nelson, K., Gaur, L.K., Andrews, R.G., and Allen, M.D.  CFSE dye dilution mixed leukocyte reactions monitor alloreactivity following cardiac transplantation in non-human primates. Transplantation Proceedings, 33:226-9, 2001.

Maniatis, A.K., Liping, Y., Miao, D., Nelson, K., and Eisenbarth, G.S. Rapid Assays for detection of anti-islet autoantibodies: Implications for organ donor screening. J Autoimmunity, 16:71-6, 2001.

He, J.Q., Gaur, L.K., Stempien-Otero, A., Nelson, K., Levy, W.C., O'Brien, K.D., Bolgiano, D.C., and Reiner, A.P.  Genetic variants of the hemostatic system and development of transplant coronary artery disease.  J Heart Lung Transplant 21:629-36, 2002.

Gaur, L.K., Nitta, Y., Kennedy, E., Lernmark, A., Nelson, K.A., Allen, M., and Nepom, G.T. Induction of islet allotolerance in nonhuman primates.
Ann N Y Acad Sci  958:199-203, 2002.

Gaur, L.K., Kennedy, E., Nitta, Y., Nepom, G.T., Nelson, K.A., Allen, M., and Lernmark, A.
Induction of donor-specific tolerance to islet allografts in nonhuman primates. Ann N Y Acad Sci 958:194-8, 2002.

Engelfriet, C.P., Reesink, H.W., Lee, K., Bierling, P., Taaning, E., Zupanska, B., Kurz, M., Hocker, P., Mayr, W.R., Panzer, S., Shibata, Y., Nelson, K.A., Gernsheimer, T.B., Kekomaki, R., Sanz, C., Pereira, A., Kiefel, V., Brand, A., Claas, F.H., Witvliet, M., Tomson, T.A., Navarrete, C., Brown, C., and Lucas, G. Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors. Vox Sang.  84(1):73-88, 2003.

Reinsmoen, N., Zeevi, A., and Nelson, K.A. Anti-HLA antibody analysis and crossmatching in heart and lung transplantation.  Transplant Immunol, 13: 63-71, 2004.

Slichter, S.J., Fish, D., Abrams, V.K., Gaur, L., Nelson, K., and Bolgiano, D.  Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model.  Blood, 105(2):847-854, 2005.

Janatjpour, K., Denning, L., Nelson, K., Betlach, B., Mackenzie, M., and Holland, P.  Comparison of X-ray vs. gamma irradiation of CPDA-1 red cells.  Vox Sang. 89(4):215-219, 2005.